Clinical Trial Update: Esketamine and Perioperative Depressive Symptoms [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating esketamine for perioperative depressive symptoms has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• Esketamine (esketamine)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Depressive Symptoms, Esketamine | Phase 2, Phase 3 | Status: COMPLETED